5VGO

Bruton's tyrosine kinase (BTK) with compound G-744

5VGO の概要

• エントリーDOI: 10.2210/pdb5vgo/pdb
• 関連するPDBエントリー: 5VFI
• 分子名称: Tyrosine-protein kinase BTK, SULFATE ION, GLYCEROL, ... (6 entities in total)
• 機能のキーワード: protein kinase, inhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• 由来する生物種: Homo sapiens (Human)
• 細胞内の位置: Cytoplasm: Q06187
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 32932.84

構造登録者

Yu, C.,Eigenbrot, C. (登録日: 2017-04-11, 公開日: 2017-07-05, 最終更新日: 2023-10-04)

主引用文献

Wang, X.,Barbosa, J.,Blomgren, P.,Bremer, M.C.,Chen, J.,Crawford, J.J.,Deng, W.,Dong, L.,Eigenbrot, C.,Gallion, S.,Hau, J.,Hu, H.,Johnson, A.R.,Katewa, A.,Kropf, J.E.,Lee, S.H.,Liu, L.,Lubach, J.W.,Macaluso, J.,Maciejewski, P.,Mitchell, S.A.,Ortwine, D.F.,DiPaolo, J.,Reif, K.,Scheerens, H.,Schmitt, A.,Wong, H.,Xiong, J.M.,Xu, J.,Zhao, Z.,Zhou, F.,Currie, K.S.,Young, W.B.
Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties.
ACS Med Chem Lett, 8:608-613, 2017

PubMed Abstract: In our continued effort to discover and develop best-in-class Bruton's tyrosine kinase (Btk) inhibitors for the treatment of B-cell lymphomas, rheumatoid arthritis, and systemic lupus erythematosus, we devised a series of novel tricyclic compounds that improved upon the druglike properties of our previous chemical matter. Compounds exemplified by are highly potent, selective for Btk, metabolically stable, well tolerated, and efficacious in an animal model of arthritis.

PubMed: 28626519
DOI: 10.1021/acsmedchemlett.7b00103

実験手法

X-RAY DIFFRACTION (1.621 Å)